Société Protagonist Therapeutics Inc Nasdaq
Actions
US74366E1029
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- PTS | - |
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01/12/08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18/04/22 |
Chief Tech/Sci/R&D Officer | - | 01/07/17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24/05/18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07/11/22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17/01/19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01/01/17 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01/09/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08/06/17 |
Harold Selick
CHM | Chairman | 69 | 01/02/09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26/10/23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01/12/08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12/08/20 |
William Waddill
BRD | Director/Board Member | 67 | 01/07/16 |
Bryan Giraudo
BRD | Director/Board Member | 49 | 16/05/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 58 652 133 | 56 902 179 ( 97,02 %) | 0 | 97,02 % |
Coordonnées société
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83 % | 46,56 Md | |
+45,38 % | 41,67 Md | |
+0,69 % | 41,16 Md | |
+30,52 % | 32,4 Md | |
+22,30 % | 28,18 Md | |
-6,35 % | 28,1 Md | |
+49,25 % | 14,52 Md | |
+49,18 % | 13,74 Md | |
+3,45 % | 12,17 Md |
- Bourse
- Actions
- Action PTGX
- Action
- Société Protagonist Therapeutics Inc